This week, Kevin McKernan, Founder and Chief Science Officer at Medicinal Genomics will be joining us on our Private and Professional forum to discuss the latest developments in cannabis IP, genetic testing, and all things cannabis from his expert position in the industry.
- Who: Kevin McKernan, CEO of Medicinal Genomics and CannMed
- What: Cannabis genomics, IP, genetic testing and marker-assisted breeding to accelerate cultivation
- Where: The GNET private forum
- When: Wednesday, July 17th at 11 AM PST
When it comes to cannabis genetics and microbial detection, Medicinal Genomics is in a class of its own. Medicinal Genomics was born from Courtagen Life Sciences, a CLIA certified genetics testing laboratory that specialized in identifying rare pediatric neurological conditions. Chief Science Officer, Kevin McKernan, worked on the Human Genome Project and was the first scientist to sequence the Cannabis genome. He and the Medicinal Genomics team of DNA experts developed a full suite of cannabis microbial detection tests that have been fully validated on the cannabis plant in an ISO-certified laboratory. The team also offers a cannabis genome sequencing service to growers, as well as a number tests that can be used for marker-selection breeding.
This has been a turbulent year in cannabis. Kevin will be here to help explain how Medicinal Genomics is adding a level of trust and transparency to cannabis. Start generating those questions HERE.